SCHEMBL14801972

SCHEMBL14801972

O=C1N=c2ccccc2=C2N=NC(F)=C12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.40
MAPT P10636 7/20 0.40
KMT2A Q03164 6/20 0.40
ALDH1A1 P00352 5/20 0.40
MEN1 O00255 4/20 0.40
POLB P06746 3/20 0.40
PKM P14618 2/20 0.40
LMNA P02545 2/20 0.40
MAPK10 P53779 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TGM2 P21980 1/20 0.39
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
CCR6 P51684 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
TLR9 Q9NR96 1/20 0.36
MAPK1 P28482 2/20 0.34
CGAS Q8N884 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9215154 0.79 ATM (0.40) ATMMAPTKMT2AALDH1A1MEN1
SCHEMBL10718655 0.76 MAPT (0.49) ATMMAPTKMT2AALDH1A1MEN1
SCHEMBL29161382 0.75 MAPT (0.54) ATMMAPTKMT2AALDH1A1MEN1
SCHEMBL6686096 0.70 ATM (0.37) ATMMAPTKMT2AALDH1A1MEN1
SCHEMBL1827818 0.68 MAPT (0.49) ATMMAPTKMT2AALDH1A1MEN1
SCHEMBL2565507 0.67 MAPT (0.35) ATMMAPTKMT2AALDH1A1MEN1
SCHEMBL4515373 0.65 ALDH1A1 (0.32) MAPTKMT2AALDH1A1MEN1POLB
Isatin SCHEMBL7073534 0.63 MAPT (0.47) ATMMAPTKMT2AALDH1A1MEN1
SCHEMBL9139763 0.63 ATM (0.41) ATMMAPTKMT2AALDH1A1MEN1
SCHEMBL1137916 0.63 MAPT (0.40) ATMMAPTKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130079337-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2013-03-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079337-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF CYP11B2, COQ8A, CYP1A2 ATM 2529/4885MAPT 2589/4885KMT2A 3452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.